Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genetic Linkage for Bipolar Disorder to the Distal Region of Chromosome 19q: A Large Family Whole Genome Sequencing Study.

Bipolar disorders·2026
Same author

From Biomarkers to New Treatments for Post-Traumatic Stress Disorder.

Neuroscience bulletin·2026
Same author

Characterizing suicidal thoughts and behaviours in individuals presenting to a psychiatric emergency department: a protocol for a multimethod approach for suicide prevention research.

BMJ open·2025
Same author

Association between dietary potassium intake and cognitive function among older adults: A cross-sectional study.

Clinical nutrition ESPEN·2025
Same author

Protein interacting with C-kinase 1 (PICK1) regulates synaptic function and reversal learning in a mouse model for schizophrenia.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology·2025
Same author

NFAT1 Signaling Contributes to Bone Cancer Pain by Regulating IL-18 Expression in Spinal Microglia.

CNS neuroscience & therapeutics·2025

Related Experiment Video

Updated: Apr 14, 2026

Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo
10:50

Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo

Published on: March 26, 2019

8.4K

Blocking GluR2-GAPDH ameliorates experimental autoimmune encephalomyelitis.

Dongxu Zhai1, Frankie H F Lee1, Cheryl D'Souza2

  • 1Department of Neuroscience, Centre for Addiction and Mental Health Toronto, Ontario, Canada, M5T 1R8.

Annals of Clinical and Translational Neurology
|April 25, 2015
PubMed
Summary
This summary is machine-generated.

A new peptide therapy targeting the GluR2-GAPDH complex shows promise for multiple sclerosis (MS) treatment. This approach reduces neurotoxicity and improves neurological function in EAE mice without suppressing immune responses.

More Related Videos

Induction of Experimental Autoimmune Encephalomyelitis in Mice and Evaluation of the Disease-dependent Distribution of Immune Cells in Various Tissues
08:47

Induction of Experimental Autoimmune Encephalomyelitis in Mice and Evaluation of the Disease-dependent Distribution of Immune Cells in Various Tissues

Published on: May 8, 2016

25.2K
Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research
05:55

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research

Published on: December 1, 2023

1.5K

Related Experiment Videos

Last Updated: Apr 14, 2026

Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo
10:50

Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo

Published on: March 26, 2019

8.4K
Induction of Experimental Autoimmune Encephalomyelitis in Mice and Evaluation of the Disease-dependent Distribution of Immune Cells in Various Tissues
08:47

Induction of Experimental Autoimmune Encephalomyelitis in Mice and Evaluation of the Disease-dependent Distribution of Immune Cells in Various Tissues

Published on: May 8, 2016

25.2K
Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research
05:55

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research

Published on: December 1, 2023

1.5K

Area of Science:

  • Neuroscience
  • Immunology
  • Pharmacology

Background:

  • Multiple sclerosis (MS) is a leading cause of neurological disability in young adults.
  • Current MS treatments focus on immune modulation, but the underlying pathophysiology remains unclear.
  • No definitive cure for MS is currently available.

Purpose of the Study:

  • To identify novel therapeutic targets for MS by investigating glutamate-mediated neurotoxicity.
  • To explore the role of the AMPA receptor interacting protein complex in MS pathophysiology.
  • To develop a peptide-based therapy to disrupt the identified target complex.

Main Methods:

  • Experimental autoimmune encephalitis (EAE) induced in mice using MOG35-55.
  • Clinical scoring to assess paralysis and neurological deficits.
  • Administration of TAT-fusion peptides targeting the GluR2-GAPDH complex.

Main Results:

  • Elevated levels of the GluR2-GAPDH complex found in MS patient tissue and EAE mice.
  • A novel peptide effectively disrupted the GluR2-GAPDH complex.
  • The peptide treatment significantly improved neurological function, reduced neuronal death, and protected against demyelination and axonal damage in EAE mice.
  • The peptide demonstrated no suppressive effects on T-cell responses or neurotransmission.

Conclusions:

  • The GluR2-GAPDH complex is a novel therapeutic target for MS.
  • This therapeutic strategy offers a new mechanism of action distinct from current immunomodulatory treatments.
  • Targeting neurotoxicity via the GluR2-GAPDH complex presents a promising avenue for MS drug development.